Loading clinical trials...
Loading clinical trials...
X-Pand is Intended to Use the DESolve Scaffold System in Treatment of CAD Patients, by Including "Real World" Use of the DESolve Scaffold Over a Broad Spectrum of Geographies, A Wide Variety of Practicing Clinicians & A Minimum Degree Of Selection Criteria
The X-Pand Registry is intended to facilitate analysis of acute \& long-term safety as well as treatment outcomes with DESolve in patients with CAD.
The Xpand Registry is a single-arm, multi-center, clinical Follow up study of patients with significant coronary stenosis who are treated with a commercially available DESolve Scaffold. The Registry is an observational study. The patients should be treated according to the current DESolve IFU, professional societies guidelines \& internal hospital guidelines.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Kerckhoff-Klinik
Bad Nauheim, Germany
Universitätsklinikum Giessen
Giessen, Germany
GPR Klinikum Rüsselsheim
Rüsselsheim am Main, Germany
Krankenhaus der Barmherzigen Brüder
Trier, Germany
St. Antonius Ziekenhuis
Nieuwegein, Netherlands
Start Date
May 13, 2015
Primary Completion Date
March 31, 2017
Completion Date
April 30, 2017
Last Updated
April 26, 2021
154
ACTUAL participants
PTCA - Desolve Scaffold
DEVICE
Lead Sponsor
Elixir Medical Corporation
Collaborators
NCT05831085
NCT05860400
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions